TL011 in Severe, Active Rheumatoid Arthritis Patients

NCT01123070 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: TL011, anti CD20, for the treatment of rheumatoid arthritis
BIOLOGICAL: MabThera infusions

Sponsor

Teva Pharmaceutical Industries, Ltd.